NEJM - Ivabradine in Stable CAD

"Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure"

"CONCLUSIONS

Among patients who had stable coronary artery disease without clinical heart failure, the addition of ivabradine to standard background therapy to reduce the heart rate did not improve outcomes. (Funded by Servier; SIGNIFY Current Controlled Trials number,ISRCTN61576291.)"

http://www.nejm.org/doi/full/10.1056/NEJMoa1406430